🧬 Prediabetes remission is not just metabolic—it's cardiovascular medicine. ❤️
A new analysis in The Lancet Diabetes & Endocrinology shows that achieving remission to normoglycaemia—not merely delaying diabetes—was associated with a ~50% reduction in cardiovascular death or heart failure hospitalisation, with benefits persisting for 20–30 years across U.S. and Chinese cohorts ⏳📉.
🔍 The message is profound and practical: normalize glucose early, protect the heart long-term. Remission may represent a measurable, durable, and globally applicable prevention target, alongside weight loss and lifestyle change.
This is prevention with a memory—and a legacy. 🧠❤️
